EPO and anemia: Ultimately all of these mechanisms lead to anemia of chronic disease, a common condition in cachexia (181) Currently, erythropoiesis-stimulating-agents such as epopoetin alpha, which has similar actions as endogenous erythropoietin, are given to treat this anemia (182).